J. Mendell

1.8k total citations
42 papers, 1.4k citations indexed

About

J. Mendell is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, J. Mendell has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Neurology. Recurrent topics in J. Mendell's work include Muscle Physiology and Disorders (16 papers), Neurogenetic and Muscular Disorders Research (10 papers) and Peripheral Neuropathies and Disorders (4 papers). J. Mendell is often cited by papers focused on Muscle Physiology and Disorders (16 papers), Neurogenetic and Muscular Disorders Research (10 papers) and Peripheral Neuropathies and Disorders (4 papers). J. Mendell collaborates with scholars based in United States, Italy and United Kingdom. J. Mendell's co-authors include J. T. Kissel, Robert C. Griggs, Richard J. Barohn, Zarife Sahenk, Rabi Tawil, W. King Engel, M. P. McDermott, Wendy King, S. DiMauro and Eugene Tan and has published in prestigious journals such as Neurology, Molecular Therapy and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

J. Mendell

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Mendell United States 18 770 301 276 229 218 42 1.4k
Anna Mazzeo Italy 25 1.1k 1.5× 360 1.2× 391 1.4× 127 0.6× 260 1.2× 86 1.9k
Ya‐Gang Xie Canada 12 755 1.0× 371 1.2× 240 0.9× 245 1.1× 88 0.4× 19 1.5k
Gaetano Vattemi Italy 23 845 1.1× 262 0.9× 185 0.7× 503 2.2× 132 0.6× 74 1.5k
W. Mortier Germany 20 974 1.3× 298 1.0× 318 1.2× 65 0.3× 363 1.7× 54 1.5k
I. Pénisson-Besnier France 21 696 0.9× 147 0.5× 232 0.8× 75 0.3× 324 1.5× 55 1.2k
Monica Sciacco Italy 29 2.2k 2.9× 497 1.7× 462 1.7× 189 0.8× 182 0.8× 90 2.9k
Kevin J. Felice United States 23 643 0.8× 350 1.2× 686 2.5× 328 1.4× 177 0.8× 65 1.7k
Meenakshi B. Bhattacharjee United States 19 662 0.9× 135 0.4× 241 0.9× 131 0.6× 83 0.4× 59 1.4k
Tsuyoshi Matsumura Japan 24 970 1.3× 254 0.8× 175 0.6× 105 0.5× 259 1.2× 106 1.5k
F. Jerusalem Germany 21 676 0.9× 355 1.2× 464 1.7× 170 0.7× 106 0.5× 75 1.3k

Countries citing papers authored by J. Mendell

Since Specialization
Citations

This map shows the geographic impact of J. Mendell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mendell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mendell more than expected).

Fields of papers citing papers by J. Mendell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mendell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mendell. The network helps show where J. Mendell may publish in the future.

Co-authorship network of co-authors of J. Mendell

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mendell. A scholar is included among the top collaborators of J. Mendell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mendell. J. Mendell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chand, Deepa H., et al.. (2020). SMA – THERAPY. Neuromuscular Disorders. 30. S120–S121. 1 indexed citations
2.
Mendell, J., Richard Shell, Kelly J. Lehman, et al.. (2019). P.351Gene-replacement therapy (GRT) in spinal muscular atrophy type 1 (SMA1): long-term follow-up from the onasemnogene abeparvovec phase 1/2a clinical trial. Neuromuscular Disorders. 29. S184–S184. 1 indexed citations
3.
Day, John, Claudia A. Chiriboga, Thomas O. Crawford, et al.. (2019). P.349Onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy Type 1 (SMA1): Pivotal phase 3 study (STR1VE) update. Neuromuscular Disorders. 29. S183–S183. 2 indexed citations
4.
Jacobs, Marni, M. James, Anna Mayhew, et al.. (2019). P.183Functional progression in dysferlinopathy: results of a 3-year natural history study. Neuromuscular Disorders. 29. S102–S102.
5.
Finkel, Richard S., John Day, Basil T. Darras, et al.. (2019). O.40Intrathecal administration of onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 2 (SMA2): phase 1/2a study (STRONG). Neuromuscular Disorders. 29. S207–S207. 4 indexed citations
6.
Mendell, J., Richard Shell, W. David Arnold, et al.. (2017). AVXS-101 phase 1 gene therapy clinical trial in SMA Type 1: end-of-Study event free survival and achievement of developmental milestones. Neuromuscular Disorders. 27. S208–S208. 10 indexed citations
7.
Wells, Daniel, Emma Heslop, Volker Straub, et al.. (2015). The TREAT-NMD Advisory Committee for Therapeutics (TACT): An innovative de-risking model to foster orphan drug development. Neuromuscular Disorders. 25. S271–S271. 1 indexed citations
8.
9.
Lewis, Sarah, Vinod Malik, K.J. Campbell, et al.. (2013). Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery. Molecular Therapy. 22(2). 338–347. 132 indexed citations
10.
Mendell, J., Christopher Shilling, N. Leslie, et al.. (2012). D.O.1 A two-tiered approach to newborn screening for Duchenne muscular dystrophy (DMD) using dried blood spots for sequential CK and DNA analysis. Neuromuscular Disorders. 22(9-10). 805–805. 1 indexed citations
11.
Barohn, Richard J., Laura Herbelin, J. T. Kissel, et al.. (2006). Pilot trial of etanercept in the treatment of inclusion-body myositis. Neurology. 66(1_suppl_1). S123–4. 80 indexed citations
12.
Kissel, J. T., M. P. McDermott, J. Mendell, et al.. (2001). Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology. 57(8). 1434–1440. 131 indexed citations
13.
Griggs, Robert C., et al.. (1995). Evaluation and Treatment of Myopathies. American Journal of Physical Medicine & Rehabilitation. 74(5). 344–344. 20 indexed citations
14.
Ptáček, Louis J., Rabi Tawil, Robert C. Griggs, et al.. (1994). Sodium channel mutations in acetazolamide‐responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology. 44(8). 1500–1500. 111 indexed citations
15.
Barohn, Richard J., April McVey, S. DiMauro, et al.. (1993). Adult acid maltase deficiency. Muscle & Nerve. 16(6). 672–676. 52 indexed citations
16.
Tan, Eugene, et al.. (1993). Acute Renal Failure Resulting From Intravenous Immunoglobulin Therapy. Archives of Neurology. 50(2). 137–139. 112 indexed citations
17.
Barohn, Richard J., et al.. (1993). Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology. 43(8). 1513–1513. 77 indexed citations
18.
Mendell, J.. (1990). Immunosuppressive Therapy in Duchenne Muscular Dystrophy: Considerations for Myoblast Transfer Studies. Advances in experimental medicine and biology. 280. 287–295. 5 indexed citations
19.
Warmolts, John R., J. Mendell, Thomas M. O’Dorisio, & Samuel Cataland. (1987). Comparison of the effects of continuous subcutaneous infusion and split-mixed injection of insulin on nerve function in type I diabetes mellitus. Journal of the Neurological Sciences. 82(1-3). 161–169. 14 indexed citations
20.
Mendell, J., et al.. (1974). The Fine Structural Differences in Human Muscle Fiber Types Based on Peroxidatic Activity. Journal of Neuropathology & Experimental Neurology. 33(5). 632–640. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Mazzeo Breakdown of academic impact, for papers by Ya‐Gang Xie Breakdown of academic impact, for papers by Gaetano Vattemi Breakdown of academic impact, for papers by W. Mortier Breakdown of academic impact, for papers by I. Pénisson-Besnier Breakdown of academic impact, for papers by Monica Sciacco Breakdown of academic impact, for papers by Kevin J. Felice Breakdown of academic impact, for papers by Meenakshi B. Bhattacharjee Breakdown of academic impact, for papers by Tsuyoshi Matsumura Breakdown of academic impact, for papers by F. Jerusalem
Rankless by CCL
2026